Nasal cytology analysis in stable COPD patients

M. Vulpi (Bari, Italy), M. Dimitri (Bari, Italy), E. Buonamico (Bari, Italy), V. Quaranta (Bari, Italy), B. Sterlicchio (Bari, Italy), V. Liotino (Bari, Italy), M. Gelardi (Bari, Italy), O. Resta (Bari, Italy)

Source: International Congress 2019 – Research and innovation in airway diseases
Session: Research and innovation in airway diseases
Session type: Thematic Poster
Number: 4266
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Vulpi (Bari, Italy), M. Dimitri (Bari, Italy), E. Buonamico (Bari, Italy), V. Quaranta (Bari, Italy), B. Sterlicchio (Bari, Italy), V. Liotino (Bari, Italy), M. Gelardi (Bari, Italy), O. Resta (Bari, Italy). Nasal cytology analysis in stable COPD patients. 4266

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytological alterations of bronchial mucosa in 194 smoking patients, suffering from COPD: The importance of endobronchial brushing
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013

Nasal mucosa biopsy in patients with severe bronchial asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Association between sputum cytology and lung function in patients with asthma and COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015


Bronchial biopsy can not be recommended to discriminate asthma and COPD in routine practice
Source: Eur Respir J 2003; 22: Suppl. 45, 413s
Year: 2003

Bronchial biopsy characteristics at different etiology of COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 407s
Year: 2005

Sputum microbiology in patients with stabile COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Endobronchial ultrasound in study of airway wall remodeling in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Analysis of microbiological colonization in COPD patients with or without bronchiectasis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


A case with positive sputum cytology of COPD GOLD II
Source: Annual Congress 2010 - Thoracic Oncology Grand Round - an interactive session
Year: 2010


Prognosis of patients with NSCLC undergoing positive pleural lavage cytology
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Prediction of imminent COPD exacerbations by sputum analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Cytomorphological markers at COPD exacerbation on bronchial biopsies data
Source: Eur Respir J 2007; 30: Suppl. 51, 404s
Year: 2007

Sputum biomarkers in stable COPD
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Sputum galactomannan in COPD patients with and without bronchiectasis
Source: International Congress 2017 – Bronchial asthma management
Year: 2017

Presence of pulmonary aspiration of sinonasal secretions in patients with chronic cough
Source: Eur Respir J 2002; 20: Suppl. 38, 451s
Year: 2002

Endobronchial microbiological colonisation in stable COPD patients with severe emphysema undergoing endoscopic lung volume reduction.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017

Silent aspiration in patients with exacerbation of COPD
Source: Eur Respir J 2016; 48: 570-573
Year: 2016


Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009